-- EUROPE RESEARCH ROUNDUP: Hikma Pharmaceuticals, Zealand Pharma
-- 
-- Fri Mar 21, 2014 01:31AM EDT
-- None



March 21 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Hikma Pharmaceuticals and Zealand Pharma, on Friday.

HIGHLIGHTS * Hikma Pharmaceuticals <HIK.L>: Jefferies cuts to hold from buy rating  * Zealand Pharma <ZELA.CO>: Jefferies cuts target price to Dkk 110 from Dkk 115; rating buyFollowing is a summary of research actions on European companies reported by Reuters on Friday. Stock entries are in alphabetical order. * Dogus Otomotiv <DOAS.IS>: Renaissance Capital cuts target to Tl 10.45 from Tl 13.10; buy  * Etalon <ETLNGq.L>: Renaissance Capital cuts price target to $5.9 from $6.6; rating buy * Ford Otomotiv <FROTO.IS>: Renaissance Capital cuts target to Tl 21 from Tl 28.20; hold  * Hikma Pharmaceuticals <HIK.L>: Jefferies cuts to hold from buy rating  * Intu Properties <INTUP.L>: Jefferies cuts target price to 270p from 344p; rating hold * Tofas Turk Otomobil <TOASO.IS>: Renaissance Cuts target to Tl 11.45 from Tl 13.90; hold